Pharmanovia India Profile
Key Indicators
- Authorised Capital ₹ 12.51 Cr
as on 16-11-2024
- Paid Up Capital ₹ 12.51 Cr
as on 16-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 66.50%
(FY 2023)
- Profit 33.32%
(FY 2023)
- Ebitda 48.42%
(FY 2023)
- Net Worth 13.56%
(FY 2023)
- Total Assets 20.56%
(FY 2023)
About Pharmanovia India
The Corporate was formerly known as Atnahs Pharma India Private Limited. The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.51 Cr and a paid-up capital of Rs 12.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Pharmanovia India Private Limited India is Nidhi Shah as COMPANY SECRETARY. Sandeep Maniyar, Gurusubramanian Gopalan, Amit Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24304GJ2020FTC114194
- Company No.
114194
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
27 Jun 2020
- Date of AGM
17 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pharmanovia India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nidhi Shah | Company Secretary | 16-Apr-2021 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurusubramanian Gopalan  | Director | 27-Jun-2020 | Current |
| Sandeep Maniyar | Director | 27-Jun-2020 | Current |
Amit Patel  | Director | 21-Sep-2020 | Current |
| Harsh Patel | Director | 21-Sep-2020 | Current |
| Santsagar Patel | Director | 29-Aug-2023 | Current |
Financial Performance of Pharmanovia India.
Pharmanovia India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.5% increase. The company also saw a substantial improvement in profitability, with a 33.32% increase in profit. The company's net worth Soared by an impressive increase of 13.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmanovia India?
In 2023, Pharmanovia India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Everonn Knowledge & Education Corridor LimitedActive 14 years 9 daysSandeep Maniyar is a mutual person
- Everonn Skill Products Development LimitedActive 13 years 5 months
Sandeep Maniyar is a mutual person
- Keystone Global Advisory Solutions Private LimitedActive 1 year 2 months
Sandeep Maniyar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmanovia India?
Pharmanovia India has a workforce of 57 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmanovia India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmanovia India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
